InvestSMART

Cambium Bio Limited (ASX: CMB) - Announcements

- Current share price for CMB : $0.430

ASX company news and announcements for Cambium Bio Limited (CMB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cambium Bio Limited (CMB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cambium Bio Limited (CMB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cambium Bio Limited (CMB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$12 Cleansing notice 16 Oct 2025 4:09PM $0.460 $0.430 fallen by 6.52%
$12 Notification regarding unquoted securities - CMB 16 Oct 2025 3:56PM $0.460 $0.430 fallen by 6.52%
$12 Application for quotation of securities - CMB 16 Oct 2025 3:54PM $0.460 $0.430 fallen by 6.52%
$12 Results of Annual General Meeting 16 Oct 2025 3:09PM $0.460 $0.430 fallen by 6.52%
$12 Cambium AGM CEO address 16 Oct 2025 10:33AM $0.460 $0.430 fallen by 6.52%
$12 Cambium Bio Signs Manufacturing MOU with Locus Cell 30 Sep 2025 1:32PM $0.520 $0.430 fallen by 17.31%
$12 Proposed issue of securities - CMB 15 Sep 2025 10:31AM $0.510 $0.430 fallen by 15.69%
$12 Notice of Annual General Meeting and Proxy form 15 Sep 2025 10:27AM $0.510 $0.430 fallen by 15.69%
$12 Cambium Bio Signs Strategic MoU with Benta SAS 5 Sep 2025 11:37AM $0.465 $0.430 fallen by 7.53%
$12 Cambium Bio Signs US$2.0M plus Licensing Deal 2 Sep 2025 1:07PM $0.465 $0.430 fallen by 7.53%
$12 FY25 Appendix 4G and Corporate Governance Statement 29 Aug 2025 4:00PM $0.470 $0.430 fallen by 8.51%
$12 FY25 Appendix 4E and Annual Report 29 Aug 2025 3:56PM $0.470 $0.430 fallen by 8.51%
$12 FY25 Appendix 4E and Annual Report 29 Aug 2025 3:56PM $0.470 $0.430 fallen by 8.51%
$12 Cleansing notice 29 Aug 2025 9:23AM $0.440 $0.430 fallen by 2.27%
$12 Application for quotation of securities - CMB 29 Aug 2025 9:21AM $0.440 $0.430 fallen by 2.27%
$12 Update - Proposed issue of securities - CMB 27 Aug 2025 11:35AM $0.360 $0.430 risen by 19.44%
$12 Placement Participant Update 27 Aug 2025 11:27AM $0.360 $0.430 risen by 19.44%
$12 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2025 11:39AM $0.460 $0.430 fallen by 6.52%
$12 Proposed issue of securities - CMB 30 Jul 2025 11:14AM $0.290 $0.430 risen by 48.28%
$12 Cambium Bio Raises A$2.12 million 30 Jul 2025 11:14AM $0.290 $0.430 risen by 48.28%
$12 Cambium Bio Clears FDA Regulatory Hurdles 11 Jul 2025 9:10AM $0.215 $0.430 risen by 100%
$12 Cambium Bio Receives Ethics Approvals 30 Jun 2025 9:23AM $0.210 $0.430 risen by 104.76%
$12 Change of Address 23 May 2025 3:56PM $0.190 $0.430 risen by 126.32%
$12 Initial Director's Interest Notice - Denese Marks 22 May 2025 4:36PM $0.190 $0.430 risen by 126.32%
$12 Final Director's Interest Notice - Barry Sechos 22 May 2025 4:35PM $0.190 $0.430 risen by 126.32%

26 - 50 of 126 results

Page 2 of 6

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.